Evidence map›Paper›PMID 39272697›Full record

ReviewDiagnostics (Basel, Switzerland)2024

Foundational Models for Pathology and Endoscopy Images: Application for Gastric Inflammation.

Hamideh Kerdegari, Kyle Higgins, Dennis Veselkov, Ivan Laponogov, Inese Polaka, Miguel Coimbra, Junior Andrea Pescino, Mārcis Leja, Mário Dinis-Ribeiro, Tania Fleitas Kanonnikoff and 1 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Gastric intestinal metaplasia: Management and surveillance strategies.World journal of gastrointestinal pathophysiology · 2026
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hamideh KerdegariDivision of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0002-1478-6687
Kyle HigginsDivision of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0003-0265-1395
Dennis VeselkovDivision of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Ivan LaponogovDivision of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Inese PolakaFaculty of Medicine, Institute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-9892-7765
Miguel CoimbraInstituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência, 3200-465 Porto, Portugal.
Junior Andrea PescinoStratejAI, Avenue Louise 209, 1050 Brussels, Belgium.
Mārcis LejaFaculty of Medicine, Institute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-0319-8855
Mário Dinis-RibeiroIRISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.ORCID 0000-0003-0121-6850
Tania Fleitas KanonnikoffInstituto Investigación Sanitaria INCLIVA, Medical Oncology Department, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2789-9082
Kirill VeselkovDivision of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0002-1164-0359

Funding

The European Union 101095359UK Research and Innovation 10058099
6 · The paper itself

Abstract

The integration of artificial intelligence (AI) in medical diagnostics represents a significant advancement in managing upper gastrointestinal (GI) cancer, which is a major cause of global cancer mortality. Specifically for gastric cancer (GC), chronic inflammation causes changes in the mucosa such as atrophy, intestinal metaplasia (IM), dysplasia, and ultimately cancer. Early detection through endoscopic regular surveillance is essential for better outcomes. Foundation models (FMs), which are machine or deep learning models trained on diverse data and applicable to broad use cases, offer a promising solution to enhance the accuracy of endoscopy and its subsequent pathology image analysis. This review explores the recent advancements, applications, and challenges associated with FMs in endoscopy and pathology imaging. We started by elucidating the core principles and architectures underlying these models, including their training methodologies and the pivotal role of large-scale data in developing their predictive capabilities. Moreover, this work discusses emerging trends and future research directions, emphasizing the integration of multimodal data, the development of more robust and equitable models, and the potential for real-time diagnostic support. This review aims to provide a roadmap for researchers and practitioners in navigating the complexities of incorporating FMs into clinical practice for the prevention/management of GC cases, thereby improving patient outcomes.

Indexed as

endoscopyfoundation modelsgastric cancerpathology

Identifiers

PMID39272697
PMCPMC11394237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.